The Endocrine Society Supports The American Diabetes Association’s

January 21st, 2010 admin

The Endocrine Society released a statement supporting the American Diabetes Association’s (ADA) new clinical practice recommendations adding the use of the A1C blood test to the traditional tests that use blood sugar measurements in the diagnosis of diabetes and pre-diabetes…


Originally posted on MedicalNewsToday

 
  Related Posts
AACE, American Diabetes Association And The Endocrine Society Joint Statement On Potential Cardiovascular Risks Associated With Rosiglitazone
Collectively, the American Association of Clinical Endocrinologists (AACE), the American Diabetes Association, and The Endocrine Society continue to carefully review the information on rosiglitazone available in the public domain and await further information from the Food and Drug Administration (FDA) following the completion of the Joint Meeting... 
American Association Of Clinical Endocrinologists Approves New Diagnosis For Diabetes
The American Association of Clinical Endocrinologists (AACE) has approved the use of A1c as an additional diagnostic criterion for type 2 diabetes. An A1c of 6.5 or greater is now considered an alternate criterion for the diagnosis of type 2 diabetes. The decision was announced in a position statement entitled “The AACE/ACE Statement on the... 
Endocrine Intervention In Surgical Patients With Diabetes Leads To Shorter Hospital Stays, Reduced Costs
New research released today indicates that endocrine intervention in surgical patients with diabetes and dysglycemia (abnormal blood sugar) accounted for shorter hospital stays and a decrease in the expense of treating these patients. This research was presented at the American Association of Clinical Endocrinologists (AACE) 19th Annual Meeting &... 
Scientific Leaders Urge Diabetes Patients To Talk With Their Doctor Before Making Changes To Their Medication Use
The Endocrine Society, American Diabetes Association and American Association of Clinical Endocrinologists issue joint statement in response to an FDA panel’s recommendation to keep rosiglitazone (Avandia) on the market The U.S…  Read More →
First Orally Bioavailable Anti-Obesity/Diabetes Peptide Drug Candidate To Be Presented At The Endocrine Society Annual Meeting In San Diego
Data demonstrating the efficacy of the first and only anti-obesity and anti-diabetic peptide drug candidate not requiring injection will be presented at the Endocrine Society Annual Meeting in San Diego, June 19-22, 2010 by Dr. Patricia Grasso. In 2000, researchers at Albany Medical College, in Albany NY, under the direction of Dr…  Read More →
American Heart Association/American College Of Cardiology Joint Science Advisory: AHA/ACC Issue Advisory On Diabetes Drugs And Heart Risk
The data are inconclusive on heart risks from a class of blood sugar-lowering drugs called thiazolidinediones (TZDs) such as pioglitazone (Actos) or rosiglitazone (Avandia), but the medications should be used with close monitoring from healthcare providers according to a joint science advisory from the American College of Cardiology and the American... 
American Diabetes Association Responds To California State Court Ruling On Children With Diabetes In Schools
The American Diabetes Association issues the following statement in response to yesterday’s California Court of Appeal ruling in the case of American Nurses Association et al. v. O’Connell, et al. (California Court of Appeal, Third Appellate District, Case No. C061150)…  Read More →
Are You Surrounded By Risk? – American Diabetes Association
To combat the growing diabetes epidemic, the American Diabetes Association is asking Americans — “What will you do to Stop Diabetes? Know your risk.” On March 23, the 22nd annual American Diabetes Association Alert Day(SM), the Association is encouraging people to join the Stop Diabetes movement by taking the Diabetes Risk Test (at... 
American Diabetes Association Statement On Blood Glucose Lowering Drugs
The American Diabetes Association does not have official position favoring or recommending against specific drugs that are approved by the FDA to lower glucose. The 2009 consensus statement on medical management of hyperglycemia in type 2 diabetes does not reflect official position of the ADA but rather the expert opinion of the authors of the paper…  Read More →
Just Drop It: The One-Size-Fits-All Approach To Blood Sugar Control, That Is
Aggressive blood sugar control does not improve survival in diabetic patients with kidney failure, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The results suggest that physicians should individualize blood sugar targets for these patients and not rely on recommendations based... 
  Related Tweets from Twitter
savvyinvest (Amanda Powlesland)  : Immune System Genes Show Links to Type 1 Diabetes (HealthDay): HealthDay - WEDNESDAY, Sept. 8 (HealthDay News... http://bit.ly/dgb1rD..
Updated : 2010-09-08T23:51:23Z   |  Reply  |  View Tweet
stevebarraza (Steve Barraza)  : #music Sleep less than 6 hours a night? Hello, diabetes... (News.com): Share With Friends: | ... http://bit.ly/9B4hCt http://bit.ly/luvsng..
Updated : 2010-09-08T23:50:49Z   |  Reply  |  View Tweet
lucasfferraz (Lucas Ferraz)  : antes era o colesterol ou a diabetes, mas agora a religião está levando as pessoas a recusarem um bom pedaço de pudim de leite condensado...
Updated : 2010-09-08T23:50:48Z   |  Reply  |  View Tweet
Elance_Jobs (Elance Jobs)  : #Jobs FDA 510k submission | Elance Job: : We have a diabetes monitor (glucometer) that we would like to have app... http://bit.ly/cnbTC4..
Updated : 2010-09-08T23:50:41Z   |  Reply  |  View Tweet
kyleThampton (Kyle Hampton)  : "Everything's a dollar" at the Dollar store. This means cheap items like Tootsie Rolls are now only sold in a foot-long 'pre-diabetes' size...
Updated : 2010-09-08T23:50:22Z   |  Reply  |  View Tweet
  Related News from Digg
No comments yet.

Spam Protection by WP-SpamFree

TOP